Form 8-K - Current report:
SEC Accession No. 0001140361-22-026910
Filing Date
2022-07-26
Accepted
2022-07-26 07:57:15
Documents
20
Period of Report
2022-07-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10039901_8k.htm   iXBRL 8-K 48401
2 EXHIBIT 4.1 brhc10039901_ex4-1.htm EX-4.1 52134
3 EXHIBIT 10.1 brhc10039901_ex10-1.htm EX-10.1 114547
4 EXHIBIT 10.2 brhc10039901_ex10-2.htm EX-10.2 12869
5 EXHIBIT 10.3 brhc10039901_ex10-3.htm EX-10.3 21237
6 EXHIBIT 10.4 brhc10039901_ex10-4.htm EX-10.4 23368
7 EXHIBIT 10.5 brhc10039901_ex10-5.htm EX-10.5 14450
8 EXHIBIT 99.1 brhc10039901_ex99-1.htm EX-99.1 18061
12 image01.jpg GRAPHIC 10873
  Complete submission text file 0001140361-22-026910.txt   522983

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA galt-20220725.xsd EX-101.SCH 3901
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20220725_lab.xml EX-101.LAB 22546
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20220725_pre.xml EX-101.PRE 16068
14 EXTRACTED XBRL INSTANCE DOCUMENT brhc10039901_8k_htm.xml XML 4245
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 221104935
SIC: 2834 Pharmaceutical Preparations